scholarly journals Emerging and Re-Emerging Diseases: Novel Challenges in Today’s World or More of the Same?

Animals ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 2382
Author(s):  
João R. Mesquita

More than 61% of all human pathogens are zoonotic, representing 75% of all emerging pathogens during the past decade. Albeit significant technological leaps in diagnostics development and disease surveillance, zoonotic emerging infectious diseases are evermore a matter of concern, particularly in modern days where global warming keeps providing ideal climatic conditions to the introduction of exotic infectious agents or disease vectors in new territories. Worryingly, the 2019 novel coronavirus epidemic acts as an extreme reminder of the role animal reservoirs play in public health, accounting for over 4,200,000 deaths worldwide until today. In this Special Issue, we approach a myriad of zoonotic infectious diseases and their complex mechanisms. This Special Issue is composed of three reviews on zoonotic diseases of African Lions, hemogregarine classification, and hepatitis E virus in Brazil, followed by one letter and one opinion piece that broadens the spectrum of disease emergence to mechanistic aspects of emerging non-communicable diseases. The Special Issue is completed by six research papers covering a wide array of emerging and re-emerging diseases of poultry, bovine, poultry and tortoises, of various nature such as parasitic, bacterial, and viral. This is a brief but assertive collection that showcases the need to address health at the animal–human–environment interface, in a One Health perspective.

2019 ◽  
Vol 147 ◽  
Author(s):  
Angel N. Desai ◽  
Lawrence C. Madoff

AbstractThis invited editorial introduces a special issue of Epidemiology & Infection while also discussing advances in emerging infectious diseases.


2020 ◽  
Author(s):  
Kenichi W. Okamoto ◽  
Virakbott Ong ◽  
Robert G. Wallace ◽  
Rodrick Wallace ◽  
Luis Fernando Chaves

For most emerging infectious diseases, including SARS-Coronavirus-2 (SARS-CoV-2), pharmaceutical intervensions such as drugs and vaccines are not available, and disease surveillance followed by isolating, contact-tracing and quarantining infectious individuals is critical for controlling outbreaks. These interventions often begin by identifying symptomatic individuals. However, by actively removing pathogen strains likely to be symptomatic, such interventions may inadvertently select for strains less likely to result in symptomatic infections. Additionally, the pathogen's fitness landscape is structured around a heterogeneous host pool. In particular, uneven surveillance efforts and distinct transmission risks across host classes can drastically alter selection pressures. Here we explore this interplay between evolution caused by disease control efforts, on the one hand, and host heterogeneity in the efficacy of public health interventions on the other, on the potential for a less symptomatic, but widespread, pathogen to evolve. We use an evolutionary epidemiology model parameterized for SARS-CoV-2, as the widespread potential for silent transmission by asymptomatic hosts has been hypothesized to account, in part, for its rapid global spread. We show that relying on symptoms-driven reporting for disease control ultimately shifts the pathogen's fitness landscape and can cause pandemics. We find such outcomes result when isolation and quarantine efforts are intense, but insufficient for suppression. We further show that when host removal depends on the prevalence of symptomatic infections, intense isolation efforts can select for the emergence and extensive spread of more asymptomatic strains. The severity of selection pressure on pathogens caused by these interventions likely lies somewhere between the extremes of no intervention and thoroughly successful eradication. Identifying the levels of public health responses that facilitate selection for asymptomatic pathogen strains is therefore critical for calibrating disease suppression and surveillance efforts and for sustainably managing emerging infectious diseases.


2016 ◽  
Vol 18 (3) ◽  
Author(s):  
Chacha D. Mangu ◽  
Christina K. Manyama ◽  
Henry Msila ◽  
Lwitiho Sudi ◽  
Godlove Chaula ◽  
...  

Emerging diseases are global threat towards human existence. Every country is exposed to potentially emergence of infectious diseases. Several factor such as changes in ecology, climate and human demographics play different roles in a complex mechanism contributing to the occurrence of infectious diseases. Important aspects towards control in case of outbreaks are surveillance, preparedness and early response. Tanzania should therefore take opportunity of the calm situation currently present, to prepare. Except for HIV/AIDS, Tanzania has not experienced a major public health threat. However, the question is, is the country safe from emerging and re-emerging infectious diseases? In this article we try to explore the danger of emerging infectious disease (EID) epidemics in Tanzania and the risks attached if an outbreak is to occur. The aim is to formulate recommendations to the government, responsible authorities and general population of what can be done to improve the level of EID preparedness in the country. In conclusion, it is important to strengthen the capacity of community and healthcare staffs on how to respond to potential infectious disease outbreaks. Community-based surveillance systems should be incorporated into the national systems for early detection of public health events. It is also critical to enhance one health approach to increase cross-sectoral information sharing, surveillance and interventional strategies as regards to preparedness and response to disease outbreaks.


2020 ◽  
Vol 287 (1932) ◽  
pp. 20201039 ◽  
Author(s):  
Andrea K. Townsend ◽  
Dana M. Hawley ◽  
Jessica F. Stephenson ◽  
Keelah E. G. Williams

The ‘social distancing’ that occurred in response to the COVID-19 pandemic in humans provides a powerful illustration of the intimate relationship between infectious disease and social behaviour in animals. Indeed, directly transmitted pathogens have long been considered a major cost of group living in humans and other social animals, as well as a driver of the evolution of group size and social behaviour. As the risk and frequency of emerging infectious diseases rise, the ability of social taxa to respond appropriately to changing infectious disease pressures could mean the difference between persistence and extinction. Here, we examine changes in the social behaviour of humans and wildlife in response to infectious diseases and compare these responses to theoretical expectations. We consider constraints on altering social behaviour in the face of emerging diseases, including the lack of behavioural plasticity, environmental limitations and conflicting pressures from the many benefits of group living. We also explore the ways that social animals can minimize the costs of disease-induced changes to sociality and the unique advantages that humans may have in maintaining the benefits of sociality despite social distancing.


2020 ◽  
Vol 5 (4) ◽  
pp. 184
Author(s):  
Nourridine Siewe ◽  
Bradford Greening ◽  
Nina H. Fefferman

Preparation for outbreaks of emerging infectious diseases is often predicated on beliefs that we will be able to understand the epidemiological nature of an outbreak early into its inception. However, since many rare emerging diseases exhibit different epidemiological behaviors from outbreak to outbreak, early and accurate estimation of the epidemiological situation may not be straightforward in all cases. Previous studies have proposed considering the role of active asymptomatic infections co-emerging and co-circulating as part of the process of emergence of a novel pathogen. Thus far, consideration of the role of asymptomatic infections in emerging disease dynamics have usually avoided considering some important sets of influences. In this paper, we present and analyze a mathematical model to explore the hypothetical scenario that some (re)emerging diseases may actually be able to maintain stable, endemic circulation successfully in an entirely asymptomatic state. We argue that an understanding of this potential mechanism for diversity in observed epidemiological dynamics may be of considerable importance in understanding and preparing for outbreaks of novel and/or emerging diseases.


Author(s):  
Michael Xiaoliang Tong ◽  
Alana Hansen ◽  
Scott Hanson-Easey ◽  
Jianjun Xiang ◽  
Scott Cameron ◽  
...  

AbstractBackgroundChina’s capacity to control and prevent emerging and re-emerging infectious diseases is critical to the nation’s population health. This study aimed to explore the capacity of Centers for Disease Control and Prevention (CDCs) in China to deal with infectious diseases now and in the future.MethodsA survey was conducted in 2015 among 973 public health professionals at CDCs in Beijing and four provinces, to assess their capacity to deal with emerging and re-emerging infectious diseases.ResultsAlthough most professionals were confident with the current capacity of CDCs to cope with outbreaks, nearly all indicated more funding was required to meet future challenges. Responses indicated that Yunnan Province faced more challenges than Anhui, Henan and Liaoning Provinces in being completely prepared and able to deal with outbreaks. Participants aged 20–39 years were more likely than those aged 40 and over to believe strategies such as interdisciplinary and international collaborations for disease surveillance and control, would assist capacity building.ConclusionThe capacity of China’s CDCs to deal with infectious diseases was excellent. However, findings suggest it is imperative to increase the number of skilled CDC staff, financial support, and strengthen county level staff training and health education programs.


2021 ◽  
Vol 14 (1) ◽  
pp. 462-468
Author(s):  
Navya Vyas ◽  
Prakash Narayanan ◽  
Vishwanath Shashidhar ◽  
Shah Hossain

Background: In the context of newly emerging diseases, global health security has gained importance in recent years. The pandemic COVID-19 has reemphasized the significance. Despite increased attention to enhance health security, the existing capacities were not optimally prepared to respond to public health threats posed by emerging infectious diseases. Objective: The objective of the study was to develop a simple tool that can help monitor and build up the critical capacity to prevent, detect, respond and help identify the gaps in the preparedness of the health system. Methods: The cross-sectional study was conducted from January 2018 – December 2018 amongst the district level health functionaries like the disease surveillance, laboratory, and the animal health focal points in the selected districts across the three South Indian states. Results: The responses received from the participants of the study were scored and categorized by domains into a biosecurity index, which was easily adaptable to all districts and easy to implement by a district official or state health officer for the initial assessment. Data acquired from this tool could be analysed to build and inform readiness and response plans for preventing and controlling health emergencies. Conclusion: The biosecurity index developed for the Indian districts was an appropriate instrument for epidemic preparedness assessment.


2020 ◽  
Author(s):  
Joshua Longbottom ◽  
Charles Wamboga ◽  
Paul R. Bessell ◽  
Steve J. Torr ◽  
Michelle C. Stanton

AbstractBackgroundSurveillance is an essential component of global programs to eliminate infectious diseases and avert epidemics of (re-)emerging diseases. As the numbers of cases decline, costs of treatment and control diminish but those for surveillance remain high even after the ‘last’ case. Reducing surveillance may risk missing persistent or (re-)emerging foci of disease. Here, we use a simulation-based approach to determine the minimal number of passive surveillance sites required to ensure maximum coverage of a population at-risk (PAR) of an infectious disease.Methodology and Principal FindingsFor this study, we use Gambian human African trypanosomiasis (g-HAT) in north-western Uganda, a neglected tropical disease (NTD) which has been reduced to historically low levels (<1000 cases/year globally), as an example. To quantify travel time to diagnostic facilities, a proxy for surveillance coverage, we produced a high spatial-resolution resistance surface and performed cost-distance analyses. We simulated travel time for the PAR with different numbers (1-170) and locations (170,000 total placement combinations) of diagnostic facilities, quantifying the percentage of the PAR within 1h and 5h travel of the facilities, as per in-country targets. Our simulations indicate that a 70% reduction (51/170) in diagnostic centres still exceeded minimal targets of coverage even for remote populations, with >95% of a total PAR of ~3million individuals living ≤1h from a diagnostic centre, and we demonstrate an approach to best place these facilities, informing a minimal impact scale back.ConclusionsOur results highlight that surveillance of g-HAT in north-western Uganda can be scaled back without reducing coverage of the PAR. The methodology described can contribute to cost-effective and equable strategies for the surveillance of NTDs and other infectious diseases approaching elimination or (re-)emergence.Author SummaryDisease surveillance systems are an essential component of public health practice and are often considered the first line in averting epidemics for (re-)emerging diseases. Regular evaluation of surveillance systems ensures that they remain operating at maximum efficiency; systems that survey diseases of low incidence, such as those within elimination settings, should be simplified to reduce the reporting burden. A lack of guidance on how to optimise disease surveillance in an elimination setting may result in added expense, and/or the underreporting of disease. Here, we propose a framework methodology to determine systematically the optimal number and placement of surveillance sites for the surveillance of infectious diseases approaching elimination. By utilising estimates of geographic accessibility, through the construction of a resistance surface and a simulation approach, we identify that the number of operational diagnostic facilities for Gambian human African trypanosomiasis in north-western Uganda can be reduced by 70% without affecting existing coverage, and identify the minimum number of facilities required to meet coverage targets. Our analysis can be used to inform the number and positioning of surveillance sites for diseases within an elimination setting. Passive surveillance becomes increasingly important as cases decline and active surveillance becomes less cost-effective; methods to evaluate how best to engage this passive surveillance capacity given facility capacity and geographic distribution are pertinent for several NTDs where diagnosis is complex. Not only is this a complicated research area for diseases approaching elimination, a well-designed surveillance system is essential for the detection of emerging diseases, with this work being topical in a climate where emerging pathogens are becoming more commonplace.


Author(s):  
Rahim Khodayari-Zarnaq ◽  
Gita Alizadeh ◽  
Gisoo Alizadeh

The emerging infectious diseases and their number one causes pose a challenge to international stability worldwide. The epidemic of emerging and re-emerging diseases causes many problems for health systems, especially for the medical staff, which require global action in this regard. Emerging infectious diseases are a growing problem for the global community that accompanies the increasing danger of severe health, environmental, economic, and social impacts. An ideal emerging disease preparedness and response environment would strive for collaboration among all sectors impacted by the area unit as a business and social commitment to enhance the capacity of nations and communities to respond to threats as they arise. This article highlights the significant issues that should be considered in emerging and re‐emerging diseases, which could help the policymakers to set effective policies for dealing with the diseases and to evaluate the impact of previous health interventions better at the community level.


Sign in / Sign up

Export Citation Format

Share Document